Floatz logo

Therapeutic Asset Ratings

13,157 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
LENALIDOMIDE
Indolent B-Cell Non-Hodgkin Lymphoma
Antengene CorporationP2BB (64)
LENALIDOMIDE
Myelodysplastic Syndrome
Medical College of WisconsinP2BB (64)
LENALIDOMIDE
Lymphoblastic Lymphoma
Therapeutic Advances in Childhood Leukemia ConsortiumP2BB (64)
LENALIDOMIDE
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
National Cancer Institute (NCI)P2BB (64)
LENALIDOMIDE
Primary Mediastinal Large B-Cell Lymphoma
David Bond, MDP2BB (64)
Letrozole
Arthropathy
ARKAY TherapeuticsP2BB (64)
LIDOCAINE
Chemotherapy-Induced Neuropathy
Hospital Ambroise Paré ParisP2BB (64)
LIDOCAINE
Fibromyalgia
Peking University Third HospitalP2BB (64)
LIDOCAINE
Spinal Cord Injury
University of Texas Rio Grande ValleyP2BB (64)
L-Methionyl-L-tyrosylglycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-arginylglycylglycine fusion protein with frataxin (human isoform 1 precursor)
Friedreich Ataxia
Larimar Therapeutics, Inc.P2BB (64)
L-Nmma
Triple-Negative Breast Carcinoma
The Methodist Hospital Research InstituteP2BB (64)
Lorigerlimab
Castration-Resistant Prostate Carcinoma
MacroGenicsP2BB (64)
MELPHALAN
Disease Related To Transplantation
M.D. Anderson Cancer CenterP2BB (64)
Metformin
Neoplasm
M.D. Anderson Cancer CenterP2BB (64)
METHOTREXATE
CD4+/CD56+ Hematodermic Neoplasm
Therapeutic Advances in Childhood Leukemia ConsortiumP2BB (64)
METHOTREXATE
Bone Marrow Failure Syndrome
Fred Hutchinson Cancer CenterP2BB (64)
METHOTREXATE
Hematologic Disorder
University of Michigan Rogel Cancer CenterP2BB (64)
NEPENTHE
Metastatic Malignant Neoplasm
Samsung Medical CenterP2BB (64)
Nilotinib
Breast Cancer
National Cancer Institute (NCI)P2BB (64)
Nivolumab
Diffuse Large B-Cell Lymphoma
David Bond, MDP2BB (64)
Nivolumab
Neuroblastoma
Instituto do Cancer do Estado de São PauloP2BB (64)
Nivolumab
Pancreatic Adenocarcinoma
Mayo ClinicP2BB (64)
Nivolumab
Refractory Malignant Neoplasm
CatalYm GmbHP2BB (64)
nnc0194-0499
Metabolic Dysfunction-Associated Steatohepatitis
Novo Nordisk A/SP2BB (64)
Obinutuzumab
Mantle Cell Lymphoma
National Cancer Institute (NCI)P2BB (64)
Showing 801 to 825 of 13,157 assets
PreviousPage 33 of 527Next